The Future of Janus Kinase Inhibitors in Inflammatory Bowel DiseaseLeonie C.S. De Vries, Geert D’Haens, Manon E. Wildenberg et al.|Journal of Crohn s and Colitis|2017Cited by 117
A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and FunctionLeonie C.S. De Vries, Manon E. Wildenberg, Perry D. Moerland et al.|Inflammatory Bowel Diseases|2019Cited by 80
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in ColitisLeonie C.S. De Vries, Wouter J. de Jonge, Mohammed Ghiboub et al.|Journal of Crohn s and Colitis|2020Cited by 23
Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with TofacitinibSara van Gennep, Geert D’Haens, Ivan C N Fung et al.|Journal of Crohn s and Colitis|2024Cited by 18